Search

RTN-001

SLx-2101 is an oral, long-acting PDE5 inhibitor developed by Surface Logix Inc. to treat Hypertension.

Tetracaine

Tetracaine is an ester local anaesthetic currently available in combination with lidocaine as a cream and patch.

RCT1100

RCT1100 is an investigational mRNA-based therapeutic that aims to treat primary ciliary dyskinesia caused by pathogenic mutations in DNAI1.[L50788]

UCB-1184197

CDP323 was originally developed by the British biopharmaceutical company Celltech plc. (now UCB S.A.) and is a putative new drug for oral treatment of multiple sclerosis. … CDP323 is an antagonist of the _vascular cell adhesion molecule 1_ (VCAM-1) binding to alpha4-integrins (other adhesion molecules), a process thought to be implicated in the pathophysiology of Multiple

Stem-cell derived exosome vesicle products

Once secreted into extracellular fluid, exosomes are taken up by their target cells or carried to distant target sites. … Various bioactive molecules (including lipids, proteins, mRNAs, and tRNAs) are used to enrich exosomes.

Thenyldiamine

Formaldehyde

A highly reactive aldehyde gas formed by oxidation or incomplete combustion of hydrocarbons.

NP-50301

NP-50301 is an ophthalmic therapeutic eye drop treating post-menopausal Dry Eye Syndrome (DES). It is being developed by Nascent Pharmaceuticals.

Methylmethionine chloride

It is also called "Vitamin U", but it is not a true vitamin.

Alicaforsen